T. Rowe Price Associates
CVET

T. Rowe Price Associates’s Covetrus, Inc. Common Stock CVET Stock Holding History

T. Rowe Price Associates’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-75,142
Closed -$1.57M – 3051
2022
Q3 		$1.57M Sell
75,142
-1,822,959
-96% -$38M ﹤0.01% 1547
2022
Q2 		$39.4M Buy
1,898,101
+66,479
+4% +$1.18M 0.01% 957
2022
Q1 		$30.8M Sell
1,831,622
-1,110,574
-38% -$19.4M ﹤0.01% 1111
2021
Q4 		$58.8M Sell
2,942,196
-2,313,781
-44% -$43.6M 0.01% 949
2021
Q3 		$95.3M Sell
5,255,977
-1,131,339
-18% -$25.9M 0.01% 787
2021
Q2 		$172M Sell
6,387,316
-1,216,969
-16% -$34M 0.02% 608
2021
Q1 		$228M Sell
7,604,285
-1,306,810
-15% -$44.6M 0.02% 519
2020
Q4 		$256M Sell
8,911,095
-174,497
-2% -$4.71M 0.03% 462
2020
Q3 		$222M Sell
9,085,592
-555,866
-6% -$12M 0.03% 460
2020
Q2 		$172M Sell
9,641,458
-1,236,251
-11% -$16.2M 0.02% 506
2020
Q1 		$88.5M Buy
10,877,709
+5,336,300
+96% +$61M 0.01% 605
2019
Q4 		$73.1M Buy
5,541,409
+982,619
+22% +$11.9M 0.01% 770
2019
Q3 		$54.2M Buy
4,558,790
+1,954,625
+75% +$36.2M 0.01% 845
2019
Q2 		$63.7M Buy
2,604,165
+448,804
+21% +$12.9M 0.01% 793
2019
Q1 		$68.6M Buy
+2,155,361
New +$76.5M 0.01% 750

Other funds holding CVET

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates's CVET Position: Q4 2022 in Review

T. Rowe Price Associates sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 75,142 shares — an estimated $1.57M sold.

T. Rowe Price Associates first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $256M in Q4 2020. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • T. Rowe Price Associates reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 75,142 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $1.57M.
  • T. Rowe Price Associates first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • T. Rowe Price Associates's Covetrus, Inc. Common Stock position peaked at $256M in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.